Fosfomycin – Antibiotic for Urinary Tract Infections
Fosfomycin is a broad-spectrum antibiotic primarily used to treat uncomplicated urinary tract infections. It works by inhibiting bacterial cell wall synthesis and is effective against many gram-positive and gram-negative pathogens.
Wissenswertes über "Fosfomycin"
Fosfomycin is a broad-spectrum antibiotic primarily used to treat uncomplicated urinary tract infections. It works by inhibiting bacterial cell wall synthesis and is effective against many gram-positive and gram-negative pathogens.
What is Fosfomycin?
Fosfomycin is an antibiotic with a unique chemical structure belonging to the phosphonic acid class of antibacterial agents. It was originally isolated from the bacterium Streptomyces fradiae and is now produced synthetically. Fosfomycin is available as an oral granule formulation (fosfomycin trometamol) and as an intravenous solution (fosfomycin sodium). It is considered a well-tolerated reserve antibiotic, particularly valuable in the era of increasing antibiotic resistance.
Indications
Fosfomycin is indicated for:
- Uncomplicated urinary tract infections (UTIs) – particularly acute cystitis in women; this is the most common use of the oral formulation
- Complicated UTIs and pyelonephritis (kidney infection) using high-dose intravenous regimens
- Infections caused by multidrug-resistant organisms, including Extended-Spectrum Beta-Lactamase (ESBL)-producing bacteria and vancomycin-resistant enterococci (VRE)
- Combination therapy for serious infections caused by Pseudomonas aeruginosa or Staphylococcus aureus
Mechanism of Action
Fosfomycin inhibits the enzyme MurA (UDP-N-acetylglucosamine enolpyruvyl transferase), which catalyzes an early and essential step in bacterial cell wall biosynthesis. By blocking this enzyme, bacteria are unable to construct a stable cell wall, ultimately leading to cell death. This mechanism of action is entirely distinct from those of other antibiotic classes such as beta-lactams or fluoroquinolones, which is why fosfomycin can remain active against bacteria resistant to these agents.
Spectrum of Activity
Fosfomycin has broad-spectrum activity against:
- Gram-positive organisms: Staphylococcus aureus (including MRSA in combination therapy), Enterococcus faecalis
- Gram-negative organisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa (in combination)
Activity against Enterococcus faecium and some other pathogens is more limited.
Dosage and Administration
Oral Administration (Fosfomycin Trometamol)
For uncomplicated UTIs, a single oral dose of 3 g fosfomycin trometamol (equivalent to 2 g fosfomycin) is recommended. This single-dose regimen offers excellent patient compliance and has been shown to be as effective as longer antibiotic courses for this indication.
Intravenous Administration (Fosfomycin Sodium)
For severe or complicated infections, high doses of 12 to 24 g per day are administered intravenously, divided into multiple doses. The exact dosage depends on the severity of infection, renal function, and body weight of the patient.
Side Effects
Fosfomycin is generally well tolerated. Possible side effects include:
- Gastrointestinal complaints such as nausea, diarrhea, and abdominal discomfort (especially with oral use)
- Headache and dizziness
- Increased sodium load with intravenous use (fosfomycin sodium contains significant amounts of sodium – caution in patients with heart failure or kidney disease)
- Elevated liver enzyme levels (rare)
- Allergic reactions (rare)
Resistance Development
Resistance to fosfomycin can develop relatively quickly during monotherapy due to the selection of spontaneous bacterial mutants. To prevent this, fosfomycin is almost always used in combination with other antibiotics for serious infections. Combination therapy also reduces the risk of treatment failure in multidrug-resistant pathogens.
Special Patient Groups
- Pregnancy: Oral fosfomycin trometamol is considered relatively safe during pregnancy and is included in clinical guidelines as an option for uncomplicated UTIs. Use should always be discussed with a treating physician.
- Renal impairment: Dose adjustment is necessary in patients with reduced kidney function, as fosfomycin is predominantly eliminated via the kidneys.
- Children: Fosfomycin may be used in children under medical supervision, with dosing based on body weight.
References
- European Medicines Agency (EMA): Assessment report on fosfomycin-containing medicinal products. EMA/CHMP/742927/2017.
- Ribera A, Benavent E, Tubau F, et al. - Fosfomycin for the treatment of multidrug-resistant bacterial infections. Clin Microbiol Infect. 2015.
- Gupta K, Hooton TM, Naber KG, et al. - International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women. Clin Infect Dis. 2011;52(5):e103-e120.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryExtrauterine
Lactate Dehydrogenase Elevation
Uridine Biosynthesis Markers
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Fosfomycin + Fosfomycin trometamol + Fosfomycin sodium + Phosphomycin